Rhythm Pharmaceuticals, Inc.
RYTM • NASDAQ • Stock Fundamentals
Rhythm Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Meeker, with a market cap of $6.0B.
Market Cap$6.0B
Employees226.0
CEODavid Meeker
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Rhythm Pharmaceuticals, Inc. FAQ
Common questions about Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. (RYTM) has a market capitalization of $6.0B and trades on NASDAQ.
Rhythm Pharmaceuticals, Inc. has approximately 226 employees.